Langford, C.A. , Khalidi, N. , Springer, J. , Friedman, M. , Hellmich, B. , Pagnoux, C. , Dehghan, N. , Gewurz‐Singer, O. , Koening, C.L. , Lin, Y.C. , Monach, P.A. , Moreland, L.W. , Fifi‐Mah, A. , Flossmann, O. , Forbess, L.J. , Lanyon, P. , Molloy, E. , Specks, U. , Spiera, R. , Yacyshyn, E. , McAlear, C.A. , Burroughs, C. , Jones, R.B. , Rhee, R.L. , Hajj‐Ali, R. , Warrington, K.J. , Cuthbertson, D. , Krischer, J.P. , Jayne, D ., and Merkel, P.A ., for the Vasculitis Clinical Research Consortium and the European Vasculitis Society (2025), A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis . Arthritis Rheumatol, 77: 1739‐1748. 10.1002/art.43272
In the Results section of the Abstract, the P value for the primary endpoint was incorrectly reported as P = 0.853. The correct value is P = 0.255.
We apologize for this error.